NAPHCON-A Drug Patent Profile
✉ Email this page to a colleague
When do Naphcon-a patents expire, and what generic alternatives are available?
Naphcon-a is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in NAPHCON-A is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naphcon-a
A generic version of NAPHCON-A was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
Summary for NAPHCON-A
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for NAPHCON-A |
DailyMed Link: | NAPHCON-A at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NAPHCON-A
US Patents and Regulatory Information for NAPHCON-A
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | NAPHCON-A | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 020226-001 | Jun 8, 1994 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |